Times Union By: Diego Mendoza-Moyers The Capital Region saw a significant jump in funding for biotech research last year from the National Institutes of Health — an increase that has allowed several local research projects to flourish into 2019, according to the Albany-based Center for Economic Growth, a regional economic development
The Capital Region’s biotech sector saw a 13.5 percent year-over-year increase in National Institutes of Health (NIH) awards in fiscal 2018. Between 20 firms and institutions, the region received 154 awards totaling $62 million. That was the eight-county region’s largest amount of NIH since fiscal 2013, according to a Center
Featured R&D projects: Portable biosensing strips for detecting food contamination Developing a blood test for autism spectrum disorder Virtual retina will aid search for blindness cure Using Light to Help Alzheimer’s Patients Detecting early stage Alzheimer’s disease Detection of chemical and biological toxins Futuristic device enables faster and more reliable
As Regeneron Pharmaceuticals helps reshape the Capital Region’s manufacturing landscape, we are also seeing local scientists making their mark in the drug discovery industry. Over the past three years, Capital Region inventors have aided nearly 70 companies and institutions obtain more than 150 patents for drugs, biological compositions and other
Wadsworth Center scores most funding since FY2012 As New York State launched a $650 million initiative to grow its life sciences cluster, Capital Region academic institutions, nonprofits and private firms in fiscal 2017 netted their largest haul of National Institutes of Health (NIH) funds in four years. Regionwide, NIH awarded
The Capital Region’s primary care providers who received federal assistance to adopt electronic health records (EHRs) are among the state’s strongest users of the technology, according to a Center for Economic Growth (CEG) analysis of data from the Office of the National Coordinator for Health Information Technology (ONC Health IT).
